Using Micro Flow Imaging (MFI) to Measure Protein Aggregation
White Paper Jan 08, 2018
Sub-visible particles are a critical quality attribute for pharmaceutical products, as protein aggregates can elicit an immunogenic response that affects the therapeutic's efficacy.
Measuring protein aggregation is a common way to get an indication of stability, and MFI is widely used in formulation studies and stability studies where aggregation measurements are needed.
Download this free white paper from Protein Simple to learn about the differences between MFI and how MFI provides crucial information about your protein therapeutic.
Related White Papers
Meeting Modern Data Integrity and Compliance RequirementsWhite Paper
The accuracy and completeness of data is crucial for safe product development and to prevent serious implications regarding human health.READ MORE
How to Identify Low-Abundance Modified Peptides with Proteomics Mass SpectrometryWhite Paper
We present a new simplicity-focused analytics methodology, called Sorcerer Score™ that allows low-abundance, modified peptides (LAMPs) to be rigorously identified within a hypothesis-driven framework based on high-accuracy precursor and fragment mass data. Accurate peptide ID is fundamental to accurate protein quantitation and post-translational modification (PTM) analysis.READ MORE
Big Data Lipidomics for Lipid Biomarker Identification and Drug DiscoveryWhite Paper
Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.
Like what you just read? You can find similar content on the communities below.Analysis & Separations Biopharma Cell Science Drug Discovery Informatics & Automation Proteomics & Metabolomics Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE